Imatinib - CAS 152459-95-5

Imatinib (STI571) is a multi-targeted receptor tyrosine kinase inhibitor that selectively inhibits the kinase activities of BCR/ABL, v-Abl, PDGFR, and c-kit with oral activity. Imatinib has antitumor activity for the treatment of chronic granulocytic leukemia.

C-Kit, SARS-CoV, PDGFR, Autophagy, Bcr-Abl

Cytoskeletal Signaling, Tyrosine Kinase/Adaptors, Microbiology/Virology, Autophagy, Angiogenesis

152359

>99.99%

C29H31N7O

493.6

CN1CCN(CC2=CC=C(C=C2)C(=O)NC2=CC(NC3=NC(=CC=N3)C3=CC=CN=C3)=C(C)C=C2)CC1

-20°C

Ice Packs

Small Compound